We have reported prevsioulsy about the decision of the prestigious National Academy of Medicine (NAM) to convene a committee of experts to examine all aspects of temporomandibular disorders (TMD). Terrie Cowley, The TMJ Association (TMJA) President, spoke at the initial meeting open to the public, and she and others from the TMJA attended a second 2-day meeting, also open to the public, held on March 28-29, 2019, in Washington, DC. Stakeholders from the patient, caregiver, and research communities as well as representatives of federal agencies, insurers, and manufacturers were invited to provide their perspectives.
The agenda was organized into five panels: TMD scope and definition; public health burden; basic and preclinical research; clinical and translational research; and care pathways. Each panel included testimony from a TMJ patient, as well as speakers addressing the panel theme, with a discussion period following the presentations. Each day concluded with a public comment period with attendees given 3-5 minutes to share their perspectives with the Committee.
For a you-are-there experience we invite you to view the online video recording of the meeting, along with the presenters' slides: http://nationalacademies.org/hmd/Activities/PublicHealth/TemporomandibularDisorders/2019-MAR-28/Videos/S0/1.aspx
Importantly, if you were not able to participate in the public comment period, you are able to share your valuable perspectives on your TMJ experience with the Committee in writing to TMDstudy@nas.edu. They are grateful for patient input to the study. The NAM committee will continue to meet throughout 2019. The committee's recommendations and the study findings will be summarized in a final report in the spring of 2020.
The third meeting of the NAM TMD Committee will be closed to the public and will convene on May 1-2, 2019.